Evexia Wealth’s AbbVie ABBV Stock Holding History

Evexia Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$227K	Buy	1,099 +8	+0.7%	+$1.77K	0.06%	77
2025 Q4	$242K	Buy	1,091 +8	+0.7%	+$1.82K	0.07%	79
2025 Q3	$249K	Buy	1,083 +8	+0.7%	+$1.63K	0.07%	75
2025 Q2	$203K	Buy	+1,075	New	+$200K	0.06%	76
2025 Q1	–	Sell	-1,056	Closed	-$201K	–	75
2024 Q4	$201K	Buy	1,056 +10	+1%	+$1.84K	0.07%	76
2024 Q3	$203K	Buy	+1,046	New	+$195K	0.07%	65

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Evexia Wealth's ABBV Position: Q1 2026 in Review

Evexia Wealth increased its AbbVie (ABBV) stake by 0.73% in Q1 2026, buying an estimated $1.77K and bringing the position to 1,099 shares worth $227K. The position accounts for 0.06% of the portfolio, ranked #77.

Evexia Wealth first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. The position peaked at $249K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Evexia Wealth held 1,099 shares of AbbVie worth $227K as of Q1 2026.
Evexia Wealth bought 8 AbbVie shares in Q1 2026, an estimated $1.77K.
AbbVie made up 0.06% of Evexia Wealth's portfolio in Q1 2026, its #77 holding.
Evexia Wealth first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
Evexia Wealth's AbbVie position peaked at $249K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Evexia Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.